Patent Expiry and Pharmaceutical Market Opportunities at the Nexus of Pricing and Innovation Policy - Innovation and Marketing in the Pharmaceutical Industry - page 282

Scott Morton F (2000) Barriers to entry, brand advertising, and generic entry in the US pharmaceu-
tical industry. Int J Ind Organ 18(7):1085-1104
FTC Staff Study (2010) pay-for-delay: how drug company pay-offs cost consumers billions. http://
www.ftc.gov/os/2010/01/100112payfordelayrpt.pdf . Accessed 8 Aug 2011
Yoshitani RS (2007) Pharmaceutical reformulation: the growth of life cycle management. http://
www.law.uh.edu/hjhlp/issues/vol_72/yoshitani_cooper.pdf . Accessed 8 Aug 2011